Skip to main navigation Skip to search Skip to main content

SBIR [Phase 2]: Exosomal Drug Formulation

Grants and Contracts Details

StatusFinished
Effective start/end date4/1/18 → 8/31/21

Funding

  • 3P Biotechnologies Incorporated: $103,200.00